Every general-practice veterinarian knows the patient.

The dog is back for scratching.

Again.

The owner has changed the food, washed the bedding, tried a new shampoo, stayed consistent with flea prevention, given the prescribed medications, and watched the skin improve—only to see the licking, chewing, erythema, odor, or recurrent lesions return several weeks later.

Or perhaps it is a cat with overgrooming and excoriations whose owner is becoming increasingly frustrated because administering medication twice a day has turned into a battle.

These cases are rarely difficult because veterinarians lack medications for pruritus.

There are now excellent commercial options for controlling itch and inflammation in many patients.

The challenge is that “itchy” is not a diagnosis, and controlling pruritus is only one part of managing an allergic or inflammatory dermatology patient.

Flea allergy, food allergy, canine atopic dermatitis, feline atopic skin syndrome, ectoparasites, bacterial infection, Malassezia overgrowth, otitis, contact factors, and numerous other conditions can produce overlapping clinical presentations.

And even after the diagnosis and therapeutic plan make sense, another problem can remain:

Can this particular pet, and this particular owner, actually use the medication the way the treatment plan requires?

That is where individualized veterinary compounding can become valuable.

Not as a replacement for a dermatologic workup, but as another tool when the medication that makes sense clinically does not quite fit the animal, the lesion, or the person who has to administer it.

The First Question Isn’t “What Can We Put on It?”

When a pruritic patient returns, the temptation is understandably to focus on the next treatment.

But recurrent pruritus often rewards going backward before moving forward.

The 2023 AAHA guidelines for allergic skin disease emphasize a systematic process that begins with a detailed history, physical examination, and minimum dermatologic database. Secondary bacterial and yeast infections, ectoparasites, otitis, food allergy, and atopy all need to be considered rather than assuming every itchy patient represents another flare of the same disease.

This distinction becomes especially important when a previously effective treatment appears to have “stopped working.”

Was the original diagnosis incomplete?

Has a secondary infection emerged?

Has flea-prevention compliance changed?

Did the owner stop giving the medication as frequently as prescribed?

Is the dog being bathed differently?

Has the season changed?

Has the disease progressed?

Or is the medication still pharmacologically appropriate—but the way it is being delivered simply isn’t working well for this animal?

Those questions lead to very different solutions.

The answer should not automatically be another medication.

Dermatology Is Often a Multimodal Problem

One reason allergic skin disease can frustrate both veterinarians and pet owners is that there may be no single intervention that addresses every component of the disease.

A patient may need management of the underlying allergic condition while simultaneously receiving treatment for secondary infection, skin-barrier support, ectoparasite control, topical therapy, diet evaluation, or short-term control of a flare.

AAHA describes management of allergic patients as multimodal and emphasizes ongoing communication with the pet’s family because these conditions frequently require long-term management rather than a quick cure.

That communication piece is easy to underestimate.

From the veterinarian’s perspective, a plan may be clinically straightforward:

Give this medication twice daily.

Use this topical therapy on the affected area.

Bathe the dog several times per week.

Continue parasite prevention.

Recheck in two weeks.

From the owner’s perspective, however, that may mean chasing a dog around the house twice a day, trying to apply an ointment through a dense coat, stopping the pet from licking it immediately afterward, bathing a 90-pound Labrador before work, and remembering which of four treatments gets used on which day.

A treatment plan can be completely rational and still be impractical.

And an impractical treatment plan eventually becomes an adherence problem.

Sometimes Treatment Failure Is Actually Delivery Failure

This is one of the most important questions a veterinarian can ask when a medication has not produced the expected result:

Did the therapy fail—or did the delivery of the therapy fail?

Consider a localized lesion.

The active ingredient may be appropriate, but perhaps the vehicle is too greasy for a hairy area.

Maybe the owner can apply a spray but cannot reliably rub in an ointment.

Maybe the prescribed volume is so small that accurate administration is difficult.

Maybe the dog immediately licks the medication off.

Maybe a cat refuses a commercially available tablet that otherwise would be perfectly reasonable therapy.

Or perhaps the owner stopped treatment early because administering it was creating so much stress that the medication became more disruptive than the condition itself.

None of those problems necessarily means the veterinarian chose the wrong therapeutic target.

They may simply mean that the dosage form does not match the patient.

That distinction is one of the places where compounding can add genuine value.

Where Topical Therapy Can Be Especially Valuable

One advantage veterinarians have when treating many dermatologic conditions is simple:

The therapeutic target is accessible.

When disease is localized to the skin, appropriately selected topical therapy can place medication directly where it is needed and, in some situations, limit unnecessary systemic exposure.

But choosing a topical medication involves more than selecting an active ingredient.

How the medication reaches and remains on the skin matters.

A veterinarian treating an interdigital lesion faces a different formulation problem from one treating a dry, sparsely haired area on the ventral abdomen.

A greasy ointment might provide excellent contact time but be difficult to apply through a dense coat.

A cream may spread easily but disappear quickly from an area the dog immediately licks.

A solution or spray may dramatically improve owner compliance in one situation while offering insufficient contact time in another.

A gel may make targeted application easier for a small lesion.

Vehicle selection can influence:

• Ease and accuracy of application
• Coverage of the affected area
• Contact time
• Owner willingness to continue treatment
• How easily medication is removed by licking or grooming
• Practicality in hairy, dry, moist, or difficult-to-reach locations
• The amount of medication that needs to be administered

This is where individualized formulation can become more than a convenience.

It allows the veterinarian and pharmacist to think about the drug, concentration, vehicle, lesion, animal, and owner as parts of the same treatment plan.

A Concrete Example: Localized Canine Atopic Dermatitis and Tacrolimus

Tacrolimus provides a useful example of why localized therapy—and formulation itself—can matter.

In a randomized controlled trial involving dogs with localized atopic dermatitis lesions on both front feet, 0.1% tacrolimus ointment applied twice daily for six weeks produced a median 63% reduction in lesion scores, compared with 3% at placebo-treated sites. Fifteen of the 20 dogs achieved at least a 50% reduction in lesion severity at tacrolimus-treated sites.

Another randomized crossover study using commercially available 0.1% tacrolimus ointment also found improvement in canine atopic dermatitis, with dogs with localized disease responding better than those with generalized disease.

Those studies support an important practical point:

Localized disease can create an opportunity for localized therapy.

There is also an earlier study that is particularly interesting from a compounding perspective.

Investigators evaluated a compounded 0.3% tacrolimus lotion in a small group of dogs with atopic dermatitis. Investigator-rated erythema improved compared with placebo, and investigator-rated pruritus improved from baseline. Owner-rated pruritus, however, did not significantly differ between treatments.

That result is useful precisely because it is not perfect.

It demonstrates that changing concentration or vehicle does not automatically make a treatment superior.

But it also illustrates why formulation questions deserve attention.

If tacrolimus is being considered for a localized lesion, the useful conversation is not simply:

“Can we compound tacrolimus?”

It is:

• What area needs to be treated?
• Is the disease localized enough for topical treatment to be practical?
• What evidence exists for the selected concentration?
• What vehicle provides appropriate contact with this particular site?
• What will the owner realistically apply consistently?
• Does an existing commercial preparation already fit those needs?
• If not, is there a legitimate reason to customize the formulation?

That is the kind of clinical problem-solving where a compounding pharmacist can add more value than simply providing another product.

Topical Therapy and Antimicrobial Stewardship

Localized treatment is also increasingly important in antimicrobial stewardship.

Updated guidance from the International Society for Companion Animal Infectious Diseases emphasizes cytology before antimicrobial treatment of canine pyoderma and recommends topical antimicrobial therapy alone as the treatment of choice for many surface and superficial infections.

That gives general-practice veterinarians an opportunity to think more deliberately about local therapy.

The question becomes more than:

“Which antimicrobial should I use?”

It becomes:

“Can I adequately treat this where it is?”

When the answer is yes, topical therapy may offer meaningful advantages.

Commercial shampoos, sprays, wipes, mousses, and other dermatologic products solve many of these problems well.

Compounding becomes particularly useful when the medication, strength, vehicle, application volume, or administration needs of the individual patient fall outside those standard options.

Where Compounding Actually Adds Value

Veterinary dermatology creates numerous situations in which the therapeutic goal is clear but the commercially available medication does not fit perfectly.

A veterinarian may encounter a patient who needs:

• A concentration that is not commercially available
• A smaller or more practical administration volume
• A different topical vehicle for a particular application site
• A formulation that is easier to apply through hair or onto a localized lesion
• Removal of an ingredient the animal cannot tolerate
• A customized oral strength for an unusually small or large patient
• A flavored oral dosage form when a commercially available tablet cannot reliably be administered
• A formulation that simplifies an otherwise burdensome treatment plan

Those are not trivial conveniences.

A medication that stays in the bottle because the owner cannot administer it has no therapeutic value.

A topical preparation that immediately ends up on the carpet—or in the dog’s mouth—may be a poor match even if the active ingredient makes perfect sense.

And a tablet that requires the owner to repeatedly divide it into an unrealistic fraction introduces unnecessary difficulty into an otherwise sound treatment plan.

The benefit of customization is more ways to make the treatment plan fit the animal who actually has to receive it.

Clinical Pearl #1: When the Itch Returns, Recheck Before You Escalate

When a treatment that previously controlled pruritus stops working, it can be tempting to increase the dose, add another therapy, or change medications.

But a return of clinical signs may indicate that something else has changed.

AAHA recommends returning to the history, physical examination, and minimum dermatologic database when a previously successful management protocol stops working.

Secondary bacterial infection, Malassezia dermatitis, otitis, ectoparasites, or changes in allergen exposure may all alter the clinical picture.

One of the most useful questions may therefore be:

“Is this truly failure of the primary therapy or has something new been layered on top of the original disease?”

That question can prevent a veterinarian from abandoning an otherwise useful long-term plan.

Clinical Pearl #2: Ask the Owner What Is Hardest About the Treatment Plan

Veterinarians routinely ask whether owners are giving the medication.

A more revealing question may be:

“Which part of this treatment plan is hardest for you to do consistently?”

The answer may have little to do with pharmacology.

Perhaps the cat cannot be pilled.

Perhaps the owner can manage once-daily treatment but not three times daily.

Perhaps a cream is difficult to apply to an interdigital lesion.

Perhaps medicating the ear has become a source of fear or aggression.

Perhaps the dog immediately licks anything applied to the distal limbs.

These details matter because adherence is not simply an owner characteristic.

It is partly a design characteristic of the treatment plan.

When possible, the prescription should be built around something the household can realistically execute.

Sometimes that means simplifying instructions.

Sometimes it means choosing a different product.

And sometimes it creates a reason to customize the medication.

Clinical Pearl #3: The Vehicle Is Part of the Therapy

When choosing a topical medication, veterinarians naturally focus on the active ingredient.

But the vehicle determines much of what happens between the prescription and the skin.

Is the area hairy or relatively hairless?

Dry or exudative?

Localized or diffuse?

Will the animal tolerate rubbing?

Does the preparation need to remain on a small lesion?

Will the pet lick the site?

Would a cream, gel, solution, spray, powder, shampoo, or another delivery system be more practical?

The answers can influence both adherence and local drug delivery.

When requesting a compounded preparation, the veterinarian and pharmacist should therefore understand where the product will be used, what the therapeutic goal is, and what practical obstacle the formulation is intended to solve.

The vehicle is not just packaging.

It is part of the treatment design.

Clinical Pearl #4: Match the Route to the Therapeutic Goal

Topical therapy can be one of the most useful tools available when the treatment target is the skin.

For localized dermatologic disease, direct treatment of the affected area can allow the veterinarian to concentrate therapy where it is needed and may reduce unnecessary systemic exposure.

But there is an important distinction between topical treatment intended to act locally and transdermal administration intended to produce systemic drug exposure.

They are not interchangeable concepts.

If the therapeutic target is systemic, moving a medication from an oral dosage form into a transdermal preparation does not automatically mean equivalent concentrations will be achieved.

Drug characteristics, vehicle, species, application site, skin condition, grooming behavior, and available pharmacokinetic evidence all matter.

This becomes especially relevant in cats.

The appeal of transdermal therapy is obvious when oral administration turns every dose into a wrestling match.

For medications with appropriate evidence, it can be an extremely useful option.

But the best sequence remains:

First define the therapeutic goal. Then choose a route capable of accomplishing it.

For a local skin problem, local delivery deserves serious consideration.

For a systemic problem, make sure the selected route can provide the exposure the treatment requires.

Secondary Infection: Use Compounding to Support Good Stewardship

Recurrent allergic patients commonly develop secondary bacterial or yeast disease.

That can create pressure to repeatedly reach for an antimicrobial because it worked during the previous flare.

Current guidance increasingly emphasizes cytology, classification of the infection, topical treatment when sufficient, and culture and susceptibility testing when systemic antimicrobial selection requires it.

For a compounding pharmacy, the opportunity is not to provide a “stronger” antimicrobial every time an infection returns.

It is to help the veterinarian deliver an appropriately selected therapy in a form that fits the patient.

That might mean adjusting a concentration or vehicle for a localized application.

It might mean making treatment of a difficult anatomical location more practical.

It might mean reducing administration volume.

Or it may simply mean confirming that a commercially available option already meets the need.

Personalization works best when it makes good clinical decision-making easier to execute.

What a Good Veterinary Compounding Pharmacy Should Actually Solve

A veterinarian may know exactly what needs to happen clinically and still have practical questions:

• Can this dose be made small enough for a five-pound cat?
• Is there a dosage form this particular animal is more likely to accept?
• Can the medication be concentrated so the owner administers less volume?
• What topical vehicles are feasible for the location being treated?
• Is the requested active ingredient stable in that vehicle?
• Can an unnecessary excipient be avoided?
• Is there a dispensing system that reduces dosing errors?
• Is the formulation technically and legally appropriate?
• Does an existing commercial option already solve the problem?

Those questions should not become another research project for a busy general-practice veterinarian.

Bring us the clinical objective and the obstacle.

For example:

“I know what medication I want, but this cat cannot be pilled.”

“This dog has a localized lesion, but the dosage form isn’t practical for the location.”

“The dose I need requires the owner to split a tablet into an unrealistic fraction.”

“The treatment is appropriate, but the current administration method is the reason the owner isn’t using it.”

From there, our pharmacy team can help evaluate feasible strengths, dosage forms, flavors, vehicles, dispensing systems, and other patient-specific options for the veterinarian to consider.

That also includes navigating the technical and regulatory side of veterinary compounding.

Veterinary preparations are subject to specific federal and state requirements, particularly when bulk drug substances are involved. You should not need to become an expert in those rules simply to determine whether a patient-specific option is possible.

That is part of our job.

If the original request is not practical or appropriate, the goal should not be to simply send the problem back to the veterinarian.

Whenever possible, we can help identify another formulation, dosage form, strength, source, or available product that still moves the treatment plan toward the same clinical objective.

You do not need to have the formulation figured out before you call us.

That is part of the value of the relationship.

The Bigger Opportunity in Veterinary Dermatology

Chronic dermatology patients can be some of the most frustrating cases in general practice.

The veterinarian is frustrated because the disease keeps returning.

The owner is frustrated because they feel as though they are constantly giving medication.

And the animal is the one living with the itch.

Better management does not necessarily mean adding another drug.

Sometimes it means revisiting the diagnosis.

Sometimes it means identifying the secondary infection that changed the response.

Sometimes it means improving client education or simplifying the treatment plan.

Sometimes it means accepting that a chronic allergic patient will require ongoing multimodal management rather than searching for one final cure.

And sometimes the therapeutic decision is sound, but the medication simply needs to fit the animal more precisely.

The dog may need a different topical vehicle.

The cat may need a dosage form the owner can actually administer.

The concentration may need to change.

The administration volume may need to shrink.

The treatment may need to become practical enough that the owner can realistically follow through.

Those are exactly the situations where veterinary compounding earns its place.

Not because every veterinary medication should be customized.

But because individual animals do not always fit standardized medication options.

For Pet Owners: When the Itch Keeps Coming Back

If your dog or cat continues scratching, licking, chewing, developing recurrent skin infections, or needing repeated treatment, the answer is not necessarily a “stronger” medication.

Recurrent skin disease deserves a veterinary evaluation to determine why the symptoms keep returning.

If your veterinarian determines that medication is appropriate but your pet has difficulty taking it—or the available dosage form does not fit the treatment plan—Custom Care may be able to prepare a patient-specific formulation prescribed by your veterinarian.

The first step is still the same:

Figure out what your pet needs clinically. Then make the medication fit that plan as well as possible.

Have a Dermatology Patient Whose Treatment Makes Sense—but the Medication Doesn’t?

You do not need to know the exact concentration, flavor, vehicle, or dosage form before contacting us.

Tell us what you are trying to accomplish clinically and what is making the current option difficult.

Our pharmacy team can help you think through patient-specific formulation options and determine what is practical and feasible.

The next time you find yourself thinking:

“I know what I want to do for this patient. I just don’t have a medication that quite fits.”

That is a good time to call us.

Selected Clinical References

• American Animal Hospital Association. 2023 AAHA Management of Allergic Skin Diseases in Dogs and Cats Guidelines.
• Loeffler A, Cain CL, Ferrer L, et al. Antimicrobial Use Guidelines for Canine Pyoderma by the International Society for Companion Animal Infectious Diseases (ISCAID). Veterinary Dermatology. 2025.
• Bensignor E, Olivry T. Treatment of Localized Lesions of Canine Atopic Dermatitis With Tacrolimus Ointment: A Blinded Randomized Controlled Trial. Veterinary Dermatology. 2005.
• Marsella R, Nicklin CF, Saglio S, Lopez J. Investigation on the Clinical Efficacy and Safety of 0.1% Tacrolimus Ointment (Protopic) in Canine Atopic Dermatitis: A Randomized, Double-Blinded, Placebo-Controlled, Cross-Over Study. Veterinary Dermatology. 2004.
• Marsella R, Nicklin CF. Investigation on the Use of 0.3% Tacrolimus Lotion for Canine Atopic Dermatitis: A Pilot Study. Veterinary Dermatology. 2002.
• U.S. Food and Drug Administration, Center for Veterinary Medicine. Guidance for Industry #256: Compounding Animal Drugs From Bulk Drug Substances.